Phnom Penh. Cambodia. December 3, 2020. KHana Monkey announces its collaboration with the Central African Republic-based Medical Cannabis Production Company (RCAnaMed).
Mr. Michaël Doté, CEO of RCAnaMed, based in Bangui, surrounded himself with experts in the cultivation of African plants for medical use to launch this industry with the full support of the relevant authorities.
He will collaborate with Khana Money (Cambodia) and KhanaMed (Thailand) and has agreed to contribute his knowledge, skills and know-how.
He will promote the rapprochement of Asian and Central African companies, engaged in the cultivation of medicinal plants and the manufacture of by-products derived from them.
He will collaborate with medical teams engaged in the use of cannabis for medical use, more generally cannabinoids that promote homeostasis at all levels of biological life, from the subcellular level to that of the organism.
With these teams, he will also collaborate in the study of pharmacopoeia treatments resulting from traditional practices and nature, in Asia and Africa, of which it is essential to establish the efficacy and harmlessness through rigorous clinical trials. .
He will collaborate on the publication of press articles on the use of medical cannabis and continental pharmacopoeias.
RCAnaMed will be associated with networks and partner platforms that sell by-products from cannabis cultivation and pharmacopoeias.
KHana Monkey is delighted that this business leader, convinced of the recovery and sustainable development of his country, can benefit Asian companies with his skills.